Nanosynth Group PLC Directorate Change (4125W)
December 22 2021 - 2:00AM
UK Regulatory
TIDMNNN
RNS Number : 4125W
Nanosynth Group PLC
22 December 2021
22 December 2021
nanosynth group plc
("nanosynth", the "Company" or the "Group")
Board change
nanosynth group plc, the AIM quoted company is pleased to
announce that Dr Gareth Cave, currently a Non-executive Director of
the Company, has today been appointed as an Executive Director and
as the Group's Chief Scientific Officer. Dr Cave's intended change
of role, which at that time was subject to contract, was announced
on 1 September 2021.
Dr Cave is a university chemistry lecturer and has spent his
academic career researching many applications of nanotechnology,
from drug delivery systems to plant food. Beyond academia, as an
active consultant, he shares his knowledge and know-how across a
plethora of industries including pharmaceutical, healthcare,
materials, agricultural, food and drink industries. In 2015 he
formed Pharm 2 Farm Ltd, a wholly owned subsidiary of nanosynth
group plc, as a university spinout, to help realise the full
commercial potential of this nanotechnology research.
He has B.Sc., M.Sc. and Ph.D. chemistry degrees from the
University of Warwick, is an active member of the Royal Society of
Chemistry and has worked as an academic in UK, USA and Australian
universities over the course of his career.
Mark Duffin, CEO commented: "I am delighted to formalise the
agreement for Gareth to become part of the Executive team as Chief
Scientific Officer. His skills and experience are ideally suited to
guiding us through this exciting and innovative time in the Group's
development."
The information contained within this announcement is deemed by
the Company to constitute inside information as stipulated under
the Market Abuse Regulations (EU) No. 596/2014 ('MAR') which has
been incorporated into UK law by the European Union (Withdrawal)
Act 2018. Upon the publication of this announcement via Regulatory
Information Service ('RIS'), this inside is now considered to be in
the public domain.
ENQUIRIES :
nanosynth group plc via IFC Advisory
Mark Duffin (Chief Executive
Officer)
SP Angel Corporate Finance LLP
Nominated Adviser and Broker
Stuart Gledhill
Caroline Rowe +44 20 3470 0470
IFC Advisory Ltd
Graham Herring
Zach Cohen +44 20 3934 6630
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOADZMZZRMGGMZM
(END) Dow Jones Newswires
December 22, 2021 02:00 ET (07:00 GMT)
Nanosynth (LSE:NNN)
Historical Stock Chart
From May 2024 to Jun 2024
Nanosynth (LSE:NNN)
Historical Stock Chart
From Jun 2023 to Jun 2024